We are live on ! Find out more
CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$32M
TCM
2
TCG Crossover Management
California
$18.4M
CC
3
Commodore Capital
New York
$17.8M +$1M +318,604 +6%
BlackRock
4
BlackRock
New York
$17M +$447K +142,081 +3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.9M +$170K +53,919 +1%
Osaic Holdings
6
Osaic Holdings
Arizona
$11M
Millennium Management
7
Millennium Management
New York
$7.38M +$950K +301,913 +15%
BBA
8
Baker Bros. Advisors
New York
$6.75M
NCM
9
Nantahala Capital Management
Connecticut
$5.89M -$334K -106,145 -5%
FCMI
10
Foresite Capital Management IV
California
$5.56M
ACM
11
Altium Capital Management
New York
$5.44M
DCM
12
DAFNA Capital Management
California
$5.26M -$299K -95,000 -5%
FCMI
13
Foresite Capital Management III
California
$5.11M
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$4.67M +$157K +50,000 +3%
LCM
15
Lynx1 Capital Management
Puerto Rico
$4.32M +$515K +163,537 +13%
State Street
16
State Street
Massachusetts
$4.22M +$76.1K +24,160 +2%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.09M +$522K +165,743 +14%
JP Morgan Chase
18
JP Morgan Chase
New York
$4.05M -$248K -78,835 -6%
AAA
19
Affinity Asset Advisors
New York
$3.96M +$472K +150,000 +13%
6CM
20
683 Capital Management
New York
$3.42M
Citadel Advisors
21
Citadel Advisors
Florida
$3.01M +$883K +280,443 +41%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$2.93M +$459K +145,965 +18%
Hudson Bay Capital Management
23
Hudson Bay Capital Management
Connecticut
$2.44M +$425K +135,000 +21%
Northern Trust
24
Northern Trust
Illinois
$2.27M +$396K +125,640 +21%
Goldman Sachs
25
Goldman Sachs
New York
$1.75M +$431K +136,996 +32%